HeiLongJiang ZBD Pharmaceutical Co., Ltd.SSE: 603567

Notice on Convening the 1st Extraordinary General Meeting in 2026

· Issued by HeiLongJiang ZBD Pharmaceutical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · · 5 pages · Chinese

Summary by 6ix AI

The meeting is scheduled for a specific date and will include both on-site and online voting options for shareholders. The notice outlines the agenda items to be discussed and voted on during the meeting, including proposals related to share repurchase and executive compensation management. Shareholders are required to register in advance to attend the meeting, with detailed instructions provided in the notice.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

Release

Notice on Convening the 1st Extraordinary General Meeting in 2026

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:

HeiLongJiang ZBD Pharmaceutical Co., Ltd. on 6ix

Earlier from HeiLongJiang ZBD Pharmaceutical

Later from HeiLongJiang ZBD Pharmaceutical

All HeiLongJiang ZBD Pharmaceutical news releases